This inventor holds 1 USPTO granted patent and 2 published patent applications and 3 EPO patents. Top assignee: Orion Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Gerd Wohlfahrt - Innovator in Pharmaceutical Research
Introduction: Gerd Wohlfahrt is an accomplished inventor based in Berlin, Germany. He is currently associated with Orion Corporation, where he contributes to advancements in pharmaceutical research. Although he does not hold any granted patents, his work is focused on developing innovative solutions for various medical conditions.
Latest Patent Applications: Gerd Wohlfahrt has been involved in several notable patent applications. One of his latest applications is for TEAD inhibitors, which relates to a compound of formula (I). Another significant application is for MAP4K1 inhibitors, which pertains to pharmaceutical compositions and combinations aimed at treating neoplastic disorders, particularly cancer, and other conditions associated with aberrant MAP4K1 signaling. These applications highlight his commitment to addressing critical health issues through innovative compounds.
Conclusion: Gerd Wohlfahrt's contributions to pharmaceutical research, particularly through his latest patent applications, demonstrate his dedication to advancing medical science. His work at Orion Corporation positions him as a key figure in the ongoing quest for effective treatments for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile